Review Survival benefit of adding carboplatin to standard anthracycline–taxane chemotherapy in triple-negative breast cancer: an updated systematic review and meta-analysis Ying Wu Li-Feng Kong Ejakpovi Emmanuel Oghenefejiro Xuan Cao De-Qian Wang Chen-Meng Tao Xiang-Yang Wang R. Qin Yao Ji Liang Yin Nov 2026 · Breast Cancer Research and Treatment · Vol 220 · 0 citations · 26 references DOI Semantic Scholar Save View source Cite { copied='apa'; setTimeout(() => { copied=null; open=false }, 1000) })" class="flex w-full items-center justify-between rounded-lg px-3 py-2 text-left text-sm hover:bg-gray-100 dark:hover:bg-ink-800"> Copy APA Copied ✓ { copied='mla'; setTimeout(() => { copied=null; open=false }, 1000) })" class="flex w-full items-center justify-between rounded-lg px-3 py-2 text-left text-sm hover:bg-gray-100 dark:hover:bg-ink-800"> Copy MLA Copied ✓ { copied='bibtex'; setTimeout(() => { copied=null; open=false }, 1000) })" class="flex w-full items-center justify-between rounded-lg px-3 py-2 text-left text-sm hover:bg-gray-100 dark:hover:bg-ink-800"> Copy BibTeX Copied ✓ Share